Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 16;21(1):774.
doi: 10.1186/s12884-021-04246-x.

The effects of betamethasone on clinical outcome of the late preterm neonates born between 34 and 36 weeks of gestation

Yas Arimi  1 , Narges Zamani  2   3 , Mamak Shariat  4 , Hossein Dalili  5
Affiliations

The effects of betamethasone on clinical outcome of the late preterm neonates born between 34 and 36 weeks of gestation

Yas Arimi et al. BMC Pregnancy Childbirth. .

Abstract

Background: Prenatal corticosteroid administration in preterm labor is one of the most important treatments available to improve neonatal outcomes; however, its beneficial effects on late preterm infants (after the 34th week of gestation) remained unknown. We aimed to assess the effects of betamethasone on the clinical condition of the late preterm infants born between 34 and 36 weeks of gestation.

Methods: This retrospective cohort study was performed on 100 consecutive infants born between 34 and 36 weeks of gestation and received betamethasone before delivery as the cases and 100 neonates with the same delivery conditions but without receiving betamethasone. All neonates were followed up within hospitalization to assess the neonatal outcome.

Results: The neonates receiving betamethasone suffered more from respiratory distress syndrome (49% versus 31%, p = 0.008, RR = 1.59 95% CI (1.12-2.27)) and requiring more respiratory support (71% versus 50%, p = 0.002, RR = 1.43 95% CI (1.13-1.80)) as compared to the control group. There was no difference between the two groups in other neonatal adverse events or death.

Conclusion: the use of betamethasone in the late preterm period (after 34 weeks of gestation) has no beneficial effects on lung maturity or preventing neonatal adverse outcomes, even may lead to increase the risk for RDS and requiring respiratory support.

Keywords: Betamethasone; Late preterm; Neonatal outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics Practice Bulletin No. 171: Management of Preterm Labor. Obstet Gynecol. 2016;128(4):e155–e164. doi: 10.1097/AOG.0000000000001711. - DOI - PubMed
    1. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. - DOI - PMC - PubMed
    1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525. - PubMed
    1. Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 1: outcomes. Nat Rev Endocrinol. 2014;10(7):391–402. doi: 10.1038/nrendo.2014.73. - DOI - PubMed
    1. Briceño-Pérez C, Reyna-Villasmil E, Vigil-De-Gracia P. Antenatal corticosteroid therapy: historical and scientific basis to improve preterm birth management. Eur J Obstet Gynecol Reprod Biol. 2019;234:32–37. doi: 10.1016/j.ejogrb.2018.12.025. - DOI - PubMed